Cost-Effectiveness of Oral Immunotherapy Treatments vs No Treatment for Peanut Allergy in Children - PubMed
5 hours ago
- #cost-effectiveness
- #peanut allergy
- #oral immunotherapy
- The study compares the cost-effectiveness of probiotic and peanut oral immunotherapy (PPOIT), peanut oral immunotherapy (OIT), and no treatment for peanut allergy in children.
- PPOIT and OIT were found to be cost-effective compared to no treatment, with OIT showing a larger effect size but no clinically meaningful difference.
- PPOIT was slightly more costly than OIT but achieved similar remission rates and better quality-of-life improvements.
- From a quality-adjusted life years (QALYs) perspective, PPOIT offers the best value.
- Key factors influencing cost-effectiveness include treatment product pricing and patient quality of life.
- The study involved 201 children aged 1 to 10 years, with data analyzed over a 10-year horizon.